ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.

クエン酸カフェインは、骨肉腫および線維肉腫においてシスプラチンの抗腫瘍効果をin vitroおよびin vivoで増強する (機械翻訳の邦題)

BMC cancer2019Abe K, Yamamoto N, Hayashi K, et al.
研究デザインその他の原著論文
対象ヒト・動物 併記

記録の確認項目

研究デザイン
その他の原著論文
対象
ヒト・動物 併記
出版年
2019
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、骨肉腫および線維肉腫細胞株(HOS、HT1080、LM8)において、シスプラチンにカフェイン、クエン酸、またはクエン酸カフェインを併用した際の殺細胞効果(細胞生存、増殖、アポトーシス)を評価した。また、マウス異所性移植モデルを用いてin vivoでの効果も検証した。その結果、全細胞株において、シスプラチンとクエン酸カフェインの併用は、シスプラチン単独や他の併用と比較して有意に抗がん効果を増強し、併用指数は1.0未満で相乗効果を示した。クエン酸カフェインはG0/G1期停止とアポトーシスを最も強く誘導し、in vivoでも最も強い抗腫瘍効果を示した。これはクエン酸カフェインがシスプラチンの効果を増強することを示した初の報告であり、新規治療法として有望である。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Background: While multiagent chemotherapy has dramatically improved the prognosis of sarcoma, the novel chemotherapeutics have hardly developed over the past 30 years. Caffeine can induce apoptosis, delays in cell cycle progression and can enhance the cytocidal effects of anti-cancer agents. Citrate has been reported to enhance the cytocidal effect of cisplatin in gastric cancer in vitro. However its effect in sarcoma cells had not been reported.Methods: This study was designed to evaluate whether the addition of caffeine, citrate, or caffeine citrate to cisplatin improved its cytocidal effect (cell survival, proliferation, and apoptosis) on human osteosarcoma (HOS), human fibrosarcoma (HT1080) and murine osteosarcoma (LM8) cell lines. We also tested the various combinations in a mouse heterotopic transplantation model in vivo. In cell survival assay, combination index (CI) of caffeine citrate was calculated as a combination of anhydrous caffeine and citric acid, and the synergy was evaluated (CI < 1.0).Results: In all cell lines, cisplatin combined with caffeine citrate significantly reinforced the anticancer effect compared with cisplatin alone, combination of cisplatin and anhydrous caffeine, and combination of cisplatin and citric acid. Moreover, CI was < 1.0 in all conditions. The anticancer agent reinforcement effect of caffeine citrate was synergy of anhydrous caffeine and citric acid. In cell proliferation and cell cycle assay revealed that caffeine citrate had most strong effect as a combination drug than caffeine and citric acid in inducing G0/G1 cell-cycle arrest with subsequent suppressed cell proliferation. In mitochondrial depolarization and caspase 3/7 activity assay revealed that caffeine citrate had most strong effect as a combination drug than caffeine and citric acid in apoptosis associated with decreased mitochondrial membrane potential. In vivo, three different drug concentrations were tested, and cisplatin combined with caffeine citrate was found to have the strongest antitumor effect.Conclusions: This is the first report demonstrating that caffeine citrate has a significantly greater potentiating effect on cisplatin than adding either caffeine or citric acid. The combination of cisplatin with caffeine citrate is a novel treatment that might hold promise for improving the outcome of osteosarcoma and fibrosarcoma, which up till now has generally not responded well to chemotherapy.

MeSH

AnimalsAntineoplastic AgentsApoptosisBone NeoplasmsCaffeineCell Cycle CheckpointsCell Line, TumorCell ProliferationCell SurvivalCentral Nervous System StimulantsCisplatinCitratesDrug SynergismDrug Therapy, CombinationFemaleFibrosarcomaHumansMembrane Potential, MitochondrialMiceMice, NudeOsteosarcomaTreatment OutcomeTumor BurdenXenograft Model Antitumor Assays

DOI 10.1186/s12885-019-5891-y

PMID 31307409

原文・出典を見る →